Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Mesa Laboratories (MLAB) over the last 15 years, with Q4 2025 value amounting to $248.2 million.

  • Mesa Laboratories' Total Liabilities fell 927.18% to $248.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $248.2 million, marking a year-over-year decrease of 927.18%. This contributed to the annual value of $273.5 million for FY2025, which is 925.17% down from last year.
  • According to the latest figures from Q4 2025, Mesa Laboratories' Total Liabilities is $248.2 million, which was down 927.18% from $251.9 million recorded in Q3 2025.
  • Mesa Laboratories' 5-year Total Liabilities high stood at $338.8 million for Q4 2023, and its period low was $195.2 million during Q1 2021.
  • Over the past 5 years, Mesa Laboratories' median Total Liabilities value was $273.5 million (recorded in 2024), while the average stood at $271.3 million.
  • As far as peak fluctuations go, Mesa Laboratories' Total Liabilities skyrocketed by 6059.99% in 2022, and later plummeted by 1927.05% in 2024.
  • Quarter analysis of 5 years shows Mesa Laboratories' Total Liabilities stood at $325.4 million in 2021, then dropped by 15.24% to $275.8 million in 2022, then increased by 22.85% to $338.8 million in 2023, then decreased by 19.27% to $273.5 million in 2024, then decreased by 9.27% to $248.2 million in 2025.
  • Its Total Liabilities was $248.2 million in Q4 2025, compared to $251.9 million in Q3 2025 and $263.2 million in Q2 2025.